[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 25, Issue 5 (Bimonthly 2021) ::
Feyz 2021, 25(5): 1244-1254 Back to browse issues page
Evaluation of factors affecting the prognosis of Covid-19 in patients with rheumatic inflammatory diseases: A retrospective multi centric cohort study
Kamal Esalatmanesh , Zahra Soleimani , Mohammadjavad Azadchehr , Alireza Saghazadeh , Roozbeh Esalatmanesh
kashan university of medical siences , esalat.kamal@yahoo.com
Abstract:   (1476 Views)
Introduction: Covid-19 is caused by the SARS-CoV-2 virus, which was first reported in December 2019 in Wuhan, China. Rheumatic diseases include a range of autoimmune disorders, chronic auto inflammatory, and multisystem disease, and those with the disease are at greater risk for developing the infection. This study was performed to evaluate the factors affecting the prognosis of Covid-19 in patients with rheumatic inflammatory diseases. Materials and Methods: This study was performed on 207 rheumatic patients with Covid-19 with PCR positive who referred to three medical centers in Kashan, Tabriz and Tehran from May 2020 to June 2021. Sampling was done by non-probability method and Convenience. The collected data were analyzed by SPSS software version 26 using Chi-square, independent t-test, analysis of variance and logistic regression. Results: The results showed that according to OR values, the chance of poor prognosis among male patients is 4.48 times higher than female patients, in patients with lung disease is 5.55 times higher than patients without lung disease; and among the patients who were in the active phase of rheumatic disease at the time of Covid-19, it is 5.09 times more than the patients who were in the inactive phase of the disease and among the patients whose CT findings were moderate to severe was 25.69 times higher than patients whose CT findings were mild and normal. Conclusion: The results of the present study showed that the prognosis of Covid-19 in rheumatic patients in men, people with underlying lung disease, patients with active phase of rheumatic disease and in those with moderate to severe involvement in CT scan of the lungs is poor.
Keywords: Rheumatic inflammatory diseases, Prognosis, Covid-19
Full-Text [PDF 1189 kb]   (820 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2021/08/14 | Revised: 2022/05/31 | Accepted: 2021/10/11 | Published: 2021/11/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Esalatmanesh K, Soleimani Z, Azadchehr M, Saghazadeh A, Esalatmanesh R. Evaluation of factors affecting the prognosis of Covid-19 in patients with rheumatic inflammatory diseases: A retrospective multi centric cohort study. Feyz 2021; 25 (5) :1244-1254
URL: http://feyz.kaums.ac.ir/article-1-4451-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 25, Issue 5 (Bimonthly 2021) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645